FOR IMMEDIATE RELEASE
MESA, Ariz. — December 27, 2021
The largest ever meta analysis looking at isthmocele formation related to cesarean section techniques was completed here at the Marchand Institute and was just published by a major medical journal and is now available online! You can read the abstract on NIH’s PubMed website here: https://pubmed.ncbi.nlm.nih.gov/34955322/ You can also see the full text of the paper here online: https://cms.galenos.com.tr/Uploads/Article_50607/TJOG-18-322-En.pdf
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###